ストックスクリーナーアプリを入手
0.8321
4.36%
-0.0379
前日終値:
$0.87
開ける：
$0.8672
24時間の取引高:
83,468
Relative Volume:
0.57
時価総額：
$6.78M
収益：
$431.40K
当期純損益:
$-1.95M
株価収益率:
-6.7213
EPS:
-0.1238
ネットキャッシュフロー:
$-726.80K
1週間 パフォーマンス:
-6.51%
1か月 パフォーマンス:
-2.89%
6か月 パフォーマンス:
-27.09%
1年 パフォーマンス:
-19.99%
1日の値動き範囲:
$0.8201
$0.8707
1週間の範囲:
$0.81
$0.9076
52週間の値動き範囲:
$0.65
$4.47
Aptorum Group Ltd Stock (APM) Company Profile
Compare APM vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APM
Aptorum Group Ltd
|
0.8321 | 6.78M | 431.40K | -1.95M | -726.80K | -0.1238 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Aptorum Group Ltd (APM) 最新ニュース
Aptorum Group Ltd (APM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aptorum Group Ltd (APM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aptorum Group Ltd (APM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aptorum Group Ltd (APM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aptorum Group Ltd (APM) Institutional Confidence - TradingKey
Aptorum Group Ltd (APM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aptorum Group Ltd (APM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aptorum Group Ltd (APM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aptorum Group Ltd (APM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
APM News | APTORUM GROUP LTD-CLASS A (NASDAQ:APM) - ChartMill
Aptorum Shareholders Approve Proposed Merger With DiamiR Biosciences - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Aptorum Group Limited Announces Board of Directors Appointments - marketscreener.com
Aptorum shareholders approve merger with DiamiR Biosciences By Investing.com - Investing.com South Africa
Aptorum Group Limited and DiamiR Biosciences Corp. Shareholders Approve Merger Transaction - Quiver Quantitative
Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences - Yahoo Finance
Aptorum Group Limited (APM) Hovers Near Support at $0.80 After Marginal DeclinePut Spread Alert - newsline.com
APM | Aptorum Group Limited Class Insider Trading - Quiver Quantitative
APM Technical Analysis | Trend, Signals & Chart Patterns | APTORUM GROUP LTD-CLASS A (NASDAQ:APM) - ChartMill
Why Is Aptorum Group Limited (APM.PA) Stock Down Today? - Meyka
TradingKey - TradingKey
Aptorum Group to Domesticate, Merge with DiamiR (NASDAQ: APM) - Stock Titan
Is Aptorum (APM) stock considered high volatility (Slight Gain) 2026-04-22Swing Trade - newser.com
Can Aptorum (APM) Stock Double in 2026 | Price at $0.93, Up 0.29%Continuation Pattern - Newser
XBIO PE Ratio & Valuation, Is XBIO Overvalued - Intellectia AI
APRE PE Ratio & Valuation, Is APRE Overvalued - Intellectia AI
APM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aptorum Group Soars Over 20% as Market Deciphers Regulatory Chaos and Sector Growth Signals - Bitget
DiamiR merger gives Aptorum (NASDAQ: APM) holders 30% of new Niki BioSolutions - stocktitan.net
Aptorum (NASDAQ: APM) to merge with DiamiR; domestication and share issuance - Stock Titan
Direxion Daily AMZN Bull 2X Shares (NASDAQ:AMZU) Short Interest Up 22.7% in March - Defense World
APTORUM GROUP PB Ratio: 0.29 | Possible Value Trap - GuruFocus
Going concern warning and high risk profile at Aptorum Group (NASDAQ: APM) - Stock Titan
Aptorum (NASDAQ: APM) delays DiamiR merger cutoff to June 30, 2026 - Stock Titan
If You Invested $1,000 in Aptorum Group Ltd (APM) - Stock Titan
Aptorum Group (APM) Stock Analysis Report | Financials & Insights - Benzinga Japan
[6-K] Aptorum Group Ltd Current Report (Foreign Issuer) | APM SEC FilingForm 6-K - Stock Titan
Aptorum, DiamiR publish glioblastoma blood test study By Investing.com - Investing.com South Africa
Aptorum, DiamiR publish glioblastoma blood test study - Investing.com Nigeria
Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - Bitget
Blood test study takes aim at glioblastoma, deadliest brain cancer - Stock Titan
User - The Chronicle-Journal
Aptorum Group Receives Nasdaq Compliance Notification - Intellectia AI
APM | Aptorum Group Limited Class FinancialsIncome Statement - Quiver Quantitative
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - The Chronicle-Journal
APM Should I Buy - Intellectia AI
Aptorum Group Limited (NASDAQ:APM) Short Interest Up 232.3% in February - Defense World
Aptorum Group Ltd (APM) Income Statement - TradingKey
APMAptorum Group Ltd Latest Stock News & Market Updates - Stock Titan
Can Aptorum Group Limited stock outperform in a bear marketTrade Risk Summary & Target Return Focused Stock Picks - mfd.ru
APM PE Ratio & Valuation, Is APM Overvalued - Intellectia AI
Aptorum Group Ltd (APM) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.44%
大文字化:
|
ボリューム (24 時間):